review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Rinaldo Bellomo | Q28321777 |
Claudio Ronco | Q28324237 | ||
Federico Nalesso | Q60758584 | ||
Massimo de Cal | Q89293323 | ||
Mark A Perazella | Q90029303 | ||
Dinna N. Cruz | Q114371810 | ||
P2093 | author name string | Valentina Corradi | |
Catalina Ocampo | |||
Dingwei Kuang | |||
P433 | issue | 3 | |
P921 | main subject | kidney disease | Q1054718 |
systematic review | Q1504425 | ||
P304 | page(s) | 361-371 | |
P577 | publication date | 2006-09-01 | |
P1433 | published in | American Journal of Kidney Diseases | Q4744250 |
P1476 | title | Extracorporeal blood purification therapies for prevention of radiocontrast-induced nephropathy: a systematic review | |
P478 | volume | 48 |
Q37810408 | Acute Kidney Injury: Current Perspectives |
Q83736582 | Acute kidney injury |
Q36183555 | Comparison of the efficacy of recombinant human brain natriuretic peptide with saline hydration in preventing contrast-induced nephropathy in patients undergoing coronary angiography with or without concomitant percutaneous coronary intervention |
Q88868587 | Contrast medium induced acute kidney injury: a narrative review |
Q35127308 | Contrast-induced acute kidney injury: short- and long-term implications |
Q55024982 | Effect of Repeated Injection of Iodixanol on Renal Function in Healthy Wistar Rats Using Functional MRI. |
Q84978295 | Evidence-based practice guideline for the treatment of CKD |
Q49604694 | High cut-off membranes in acute kidney injury and continuous renal replacement therapy |
Q38789239 | Imaging patients with renal impairment |
Q42315363 | N-acetyl cysteine versus allopurinol in the prevention of contrast nephropathy in patients with chronic kidney disease: A randomized controlled trial |
Q27023336 | Nonpharmacological strategies to prevent contrast-induced acute kidney injury |
Q50054523 | Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines |
Q46164825 | Preventing contrast-induced nephropathy in patients with baseline renal dysfunction undergoing coronary angiography |
Q35999430 | Preventing radiocontrast-induced nephropathy in chronic kidney disease patients undergoing coronary angiography |
Q37634355 | Prevention of acute kidney injury and protection of renal function in the intensive care unit. Expert opinion of the Working Group for Nephrology, ESICM. |
Q46866113 | Prophylactic hemodialysis for the prevention of contrast-induced nephropathy after coronary angiography. |
Q38445166 | Renal-related adverse effects of intravenous contrast media in computed tomography |
Q37635437 | Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis |
Q35574190 | The prevention of acute kidney injury an in-depth narrative review: Part 2: Drugs in the prevention of acute kidney injury |
Q42369325 | Timing of RRT initiation in critically-ill patients: time for precision medicine |
Q22306013 | Toxicity of MRI and CT contrast agents |
Q38851069 | Use of Radiocontrast Agents in CKD and ESRD. |
Q52923652 | [Iodinated contrast agent-induced nephropathy]. |
Search more.